Hijacking Suppression: Anti-CD40 Converts Regulatory T Cells Into Type I Effectors

被引：0
|
作者：
Maltez, Vivien [1 ]
Arora, Charu [1 ]
Sor, Rina [1 ]
Lian, Qiaoshi [1 ]
Vonderheide, Robert [1 ]
Germain, Ronald [1 ]
Byrne, Katelyn [1 ]
机构：
[1] NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2023年 / 299卷 / 03期
关键词：
D O I：
10.1016/j.jbc.2023.104324
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1527
引用
收藏
页码：S723 / S723
页数：1
相关论文
共 50 条
  • [1] Hijacking Suppression: Anti-CD40 Converts Regulatory T Cells Into Type I Effectors
    Maltez, Vivien Ileana
    Arora, Charu
    Sor, Rina
    Lian, Qiaoshi
    Vonderheide, Robert H.
    Germain, Ronald N.
    Byrne, Kateyln T.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [2] Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells:: the Janus face of anti-CD40
    de Herve, MGD
    Durali, D
    Tran, TA
    Maigné, G
    Simonetta, F
    Leclerc, P
    Delfraissy, JF
    Taoufik, Y
    BLOOD, 2005, 106 (08) : 2806 - 2814
  • [3] Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity
    Yu, Xiaojie
    Chan, H. T. Claude
    Fisher, Hayden
    Penfold, Christine A.
    Kim, Jinny
    Inzhelevskaya, Tatyana
    Mockridge, C. Ian
    French, Ruth R.
    Duriez, Patrick J.
    Douglas, Leon R.
    English, Vikki
    Verbeek, J. Sjef
    White, Ann L.
    Tews, Ivo
    Glennie, Martin J.
    Cragg, Mark S.
    CANCER CELL, 2020, 37 (06) : 850 - +
  • [4] Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice
    Blair, Paul A.
    Chavez-Rueda, Karina A.
    Evans, Jamie G.
    Shlomchik, Mark J.
    Eddaoudi, Ayad
    Isenberg, David A.
    Ehrenstein, Michael R.
    Mauri, Claudia
    JOURNAL OF IMMUNOLOGY, 2009, 182 (06): : 3492 - 3502
  • [5] Agonistic antiCD40 converts regulatory T cells in to Type 1 effector cells within the tumor microenvironment
    Maltez, Vivien
    Arora, Charu
    Sor, Rina
    Germain, Ronald N.
    Vonderheide, Robert H.
    Byrne, Katelyn T.
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Combination of Novel Anti-CD45RB and Anti-CD40 Chimeric Antibodies Promotes Operational Tolerance and Induction of T Regulatory Cells in Cynomolgus Monkey Renal Allograft Recipients
    Yang, H.
    Arp, J.
    Ma, Y.
    Welch, I.
    Haig, A.
    Liu, W.
    Reimann, K.
    Jevnikar, A.
    Rothstein, D.
    TRANSPLANTATION, 2014, 98 : 25 - 26
  • [7] A novel anti-CD40 antibody prevents activation of alloreactive T cells and prolongs skin allograft survival
    Jangalwe, Sonal N.
    Ralph, Kerry
    Ramanujam, Meera
    Greiner, Dale L.
    Brehm, Michael A.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [8] T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody
    Tutt, AL
    O'Brien, L
    Hussain, A
    Crowther, GR
    French, RR
    Glennie, MJ
    JOURNAL OF IMMUNOLOGY, 2002, 168 (06): : 2720 - 2728
  • [9] Combination of Novel Anti-CD45RB and Anti-CD40 Chimeric Antibodies Promotes Operational Tolerance and Induction of T Regulatory Cells in Cynomolgus Monkey Renal Allograft Recipients.
    Yang, H.
    Arp, J.
    Ma, Y.
    Welch, I.
    Haig, A.
    Liu, W.
    Reimann, K.
    Jevnikar, A.
    Rothstein, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 25 - 26
  • [10] Sensitivity of HIV type 1 primary isolates to human Anti-CD40 antibody-mediated suppression is related to coreceptor use
    Abayneh, Sisay A.
    Ellmark, Peter
    Karlsson, Ulf
    Andersson, Henrik
    Borrebaeck, Carl A. K.
    Karlsson, Ingrid
    Fenyo, Eva Maria
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (03) : 447 - 452
12345